Exosome Diagnostic and Therapeutic Market size was valued at USD 89.74 Million in 2023 and the total Exosome Diagnostic and Therapeutic Market revenue is expected to grow at a CAGR of 34.9% from 2024 to 2030, reaching nearly USD 729.57 Million by 2030.Exosome Diagnostic and Therapeutic Market Dynamics:
The Research Report gives a detailed account of the drivers and restraints in the exosome diagnostic and therapeutic market. Exosomes can transfer molecules from one cell to another via membrane vesicle trafficking, thus influencing the immune system, like dendritic cells and B cells, and may play a functional role in mediating adaptive immune responses to pathogens and tumors.The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis. Exosomes are related with immune responses, viral pathogenicity, pregnancy, cardiovascular diseases, central nervous system associated diseases, and cancer progression. Proteins, metabolites, and nucleic acids delivered by exosomes into recipient cells effectively alter their biological response. The growing incidence of the chronic disease such as cancer and its necessity for screening and diagnosing is one of the significant factors prompting the demand of the global exosomes diagnostic and therapeutic market. The high therapeutics potential of exosomes is one of the vital factors stimulating the demand of this market. The inherent property of exosomes in regulating complex intracellular pathways has advanced their latent usefulness in the therapeutic control of several diseases, containing neurodegenerative conditions and cancer.To know about the Research Methodology :- Request Free Sample Report Exosomes can be engineered to deliver varied therapeutic payloads, containing chemotherapeutic agents, short interfering RNAs, antisense oligonucleotides, and immune modulators, with a capability to direct their delivery to a desired target. Furthermore to their therapeutic potential, exosomes also have the ability to help in disease diagnosis. Exosomes-based liquid biopsy highlights their ability usefulness in diagnosis and determining the prognosis of patients with cancer and other diseases. Disease progression and response to therapy may also be discovered by a multicomponent analysis of exosomes. However, absence of validation requirement and standardization for the isolation of exosomes is projected to hinder the growth of this market.
Exosome Diagnostic and Therapeutic Market Segment analysis:
Based on the Application, the diagnostic segment is anticipated to grow at a CAGR of xx% throughout the forecast period. The diagnostic application segment accounted for around two-thirds share of the general exosome diagnostic and therapeutic market. Surge in demand for exosome as a biomarker in the diagnosis of cancer, and rise in incidence of cancer with increase in aged population and changes in lifestyle are the main factors that attribute to the escalation in growth of this market.Exosome Diagnostic and Therapeutic Market Regional analysis:
The North American region has dominated the market with US$ xx Mn. The development in the exosome diagnostic and therapeutic market in these regions attributes to the technical progress in the isolation of exosomes, inventive and progressive applications of exosome-based products, and aged population together with upsurge in occurrence of diseases like cancer and cardiovascular diseases. U.S. will show a high demand for exosome diagnostic and therapeutic market due to technological developments. The growing expenses in healthcare industry will propel the industry growth in U.S. confirming quality diagnosis for cancer. Nicotine addiction and enhancing pollution have given surge to emergent occurrences of cancer that have created an appearance for chemotherapies and precise diagnosis. The above-mentioned factors have boosted the market demand in North America. The objective of the report is to present a comprehensive analysis of the Global Exosome Diagnostic and Therapeutic Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analysed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Exosome Diagnostic and Therapeutic Market dynamics, structure by analysing the market segments and projects the Global Exosome Diagnostic and Therapeutic Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Exosome Diagnostic and Therapeutic Market make the report investor’s guide.Exosome Diagnostic and Therapeutic Industry Ecosystem
Exosome Diagnostic and Therapeutic Market Scope: Inquire before buying
Global Exosome Diagnostic and Therapeutic Market Report Coverage Details Base Year: 2023 Forecast Period: 2024-2030 Historical Data: 2018 to 2023 Market Size in 2023: USD 89.74 Mn. Forecast Period 2024 to 2030 CAGR: 34.9% Market Size in 2030: USD 729.57 Mn. Segments Covered: by Product Instrument Reagent Software by Application Diagnostic Therapeutic by End-User Cancer Institute Hospital Diagnostic Center Others Global Exosome Diagnostic and Therapeutic Market, by Region:
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, Turkey, Russia and Rest of Europe) Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina, Columbia and Rest of South America)Exosome Diagnostic and Therapeutic Market Key Players:
1. Aethlon Medical, Inc. 2. Biocat Gmbh 3. Capricor Therapeutics, Inc. 4. Codiak Biosciences 5. Evox Therapeutics Ltd. 6. Exosome Diagnostics Inc. 7. Hansabiomed Life Sciences Ltd. 8. Hitachi Chemical Diagnostics, Inc. 9. Malvern Instruments Ltd. 10. Mbl International Corporation 11. Nanosomix Inc. 12. Sistemic Ltd. 13. System Biosciences (Sbi) 14. Thermo Fisher Scientific Inc. 15. Qiagen N.V. 16. NX Pharmagen. 17. AMS Biotechnology Limited 18. 101BIO Therapeutic Solutions International 19. BioRegenerative Sciences 20. Cell Guidance Systems 21. ExoCyte Therapeutics 22. Evomic ScienceFrequently Asked Questions:
1. Which region has the largest share in the Global market? Ans: North American region held the highest share in 2023. 2. What is the growth rate of the Global market? Ans: The Global market is expected to grow at a CAGR of 34.9% during the forecast period 2024-2030. 3. What is the scope of the Global market Report? Ans: Global market report helps with the PESTEL, PORTER, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in the Global market? Ans: The important key players in the Global Exosome Diagnostic and Therapeutic Market are – Aethlon Medical, Inc., Biocat Gmbh, Capricor Therapeutics, Inc., Codiak Biosciences, Evox Therapeutics Ltd., Exosome Diagnostics Inc., Hansabiomed Life Sciences Ltd., Hitachi Chemical Diagnostics, Inc., Malvern Instruments Ltd., Mbl International Corporation, Nanosomix Inc., Sistemic Ltd., System Biosciences (Sbi), and Thermo Fisher Scientific Inc 5. What is the study period of this market? Ans: The Global market is studied from 2018 to 2030.
1. Exosome Diagnostic and Therapeutic Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Global Exosome Diagnostic and Therapeutic Market: Competitive Landscape 2.1. MMR Competition Matrix 2.2. Competitive Landscape 2.3. Market share analysis of major players 2.4. Key Players Benchmarking 2.4.1. Company Name 2.4.2. Business Segment 2.4.3. End-user Segment 2.4.4. Growth Rate (Y-O-Y %) 2.4.5. Revenue (2023) 2.4.6. Profit Margin 2.4.7. Market Share 2.4.8. Key Development 2.5. Market Size Estimation Methodology 2.5.1. Bottom-Up Approach 2.5.2. Top-Down Approach 2.6. Industry Ecosystem 2.6.1. Key players in the Exosome Diagnostic and Therapeutic Industry ecosystem 2.6.2. Role and Impact of Companies Exosome Diagnostic and Therapeutic Industry Ecosystem 2.7. Market Structure 2.7.1. Market Leaders 2.7.2. Market Followers 2.7.3. Emerging Players 2.8. Mergers and Acquisitions Details 3. Exosome Diagnostic and Therapeutic Market: Dynamics 3.1. Exosome Diagnostic and Therapeutic Market Trends 3.2. Exosome Diagnostic and Therapeutic Market Dynamics 3.2.1.1. Drivers 3.2.1.2. Restraints 3.2.1.3. Opportunities 3.2.1.4. Challenges 3.3. PORTER’s Five Forces Analysis 3.3.1. Customer Bargaining Power 3.3.2. Supplier Bargaining Power 3.3.3. Threat of New Entrants 3.3.4. Rivalry of Competitors 3.3.5. Threat of Substitute Products 3.4. PESTLE Analysis 3.5. Value Chain Analysis 3.6. Supply Chain Analysis 3.7. Regulatory Landscape By Region 3.7.1. Regulations Related to Exosome Diagnostic and Therapeutic Market 3.7.2. Regulatory Bodies, Government Agencies, and Other Organizations 3.8. Key Opinion Leader Analysis for the Exosome Diagnostic and Therapeutic Market 3.9. Price Analysis 3.9.1. Average Selling Price Trend of Key Players, By Product 3.9.2. Average Selling Price Trend, By Region 3.10. Pipeline Analysis 3.10.1. Pipeline Analysis Exosome Therapeutics 3.10.2. Pipeline Analysis Exosome Diagnostics 3.11. Patent Analysis 3.11.1. Key Companies with the Highest number of Patents 3.11.2. Patent Registration Analysis 3.11.3. Number of Patents Granted Still 2024 3.11.4. Legal Status of Patents Field in Exosome Diagnostic and Therapeutic Market 3.12. Technology Analysis 3.12.1. Key Technologies 3.12.2. Complimentary Technologies 3.12.3. Adjacent Technologies 3.13. Investment and Funding Scenario 4. Exosome Diagnostic and Therapeutic Market: Global Market Size and Forecast By Segmentation (By Value in USD Bn) (2023-2030) 4.1. Exosome Diagnostic and Therapeutic Market Size and Forecast, By Product(2023-2030) 4.1.1. Instrument 4.1.2. Reagent 4.1.3. Software 4.2. Exosome Diagnostic and Therapeutic Market Size and Forecast, By Application(2023-2030) 4.2.1. Diagnostic 4.2.2. Therapeutic 4.3. Exosome Diagnostic and Therapeutic Market Size and Forecast, By End-User(2023-2030) 4.3.1. Hospitals 4.3.2. Fitness Clubs & Wellness Centers 4.3.3. Home Users 5. North America Exosome Diagnostic and Therapeutic Market Size and Forecast By Segmentation (By Value in USD Million) (2023-2030) 5.1. North America Exosome Diagnostic and Therapeutic Market Size and Forecast, By Product(2023-2030) 5.1.1. Instrument 5.1.2. Reagent 5.1.3. Software 5.2. North America Exosome Diagnostic and Therapeutic Market Size and Forecast, By Application(2023-2030) 5.2.1. Diagnostic 5.2.2. Therapeutic 5.3. North America Exosome Diagnostic and Therapeutic Market Size and Forecast, By End-User(2023-2030) 5.3.1. Cancer Institute 5.3.2. Hospital 5.3.3. Diagnostic Center 5.3.4. Others 5.4. North America Exosome Diagnostic and Therapeutic Market Size and Forecast, By Country (2023-2030) 5.4.1. United States 5.4.1.1. United States Exosome Diagnostic and Therapeutic Market Size and Forecast, By Product(2023-2030) 5.4.1.1.1. Instrument 5.4.1.1.2. Reagent 5.4.1.1.3. Software 5.4.1.2. United States Exosome Diagnostic and Therapeutic Market Size and Forecast, By Application(2023-2030) 5.4.1.2.1. Diagnostic 5.4.1.2.2. Therapeutic 5.4.1.3. United States Exosome Diagnostic and Therapeutic Market Size and Forecast, By End-User(2023-2030) 5.4.1.3.1. Cancer Institute 5.4.1.3.2. Hospital 5.4.1.3.3. Diagnostic Center 5.4.1.3.4. Others 5.4.2. Canada 5.4.2.1. Canada Exosome Diagnostic and Therapeutic Market Size and Forecast, By Product(2023-2030) 5.4.2.1.1. Instrument 5.4.2.1.2. Reagent 5.4.2.1.3. Software 5.4.2.2. Canada Exosome Diagnostic and Therapeutic Market Size and Forecast, By Application(2023-2030) 5.4.2.2.1. Diagnostic 5.4.2.2.2. Therapeutic 5.4.2.3. Canada Exosome Diagnostic and Therapeutic Market Size and Forecast, By End-User(2023-2030) 5.4.2.3.1. Cancer Institute 5.4.2.3.2. Hospital 5.4.2.3.3. Diagnostic Center 5.4.2.3.4. Others 5.4.3. Mexico 5.4.3.1. Mexico Exosome Diagnostic and Therapeutic Market Size and Forecast, By Product(2023-2030) 5.4.3.1.1. Instrument 5.4.3.1.2. Reagent 5.4.3.1.3. Software 5.4.3.2. Mexico Exosome Diagnostic and Therapeutic Market Size and Forecast, By Application(2023-2030) 5.4.3.2.1. Diagnostic 5.4.3.2.2. Therapeutic 5.4.3.3. Mexico Exosome Diagnostic and Therapeutic Market Size and Forecast, By End-User(2023-2030) 5.4.3.3.1. Cancer Institute 5.4.3.3.2. Hospital 5.4.3.3.3. Diagnostic Center 5.4.3.3.4. Others 6. Europe Exosome Diagnostic and Therapeutic Market Size and Forecast By Segmentation (By Value in USD Million) (2023-2030) 6.1. Europe Exosome Diagnostic and Therapeutic Market Size and Forecast, By Product(2023-2030) 6.2. Europe Exosome Diagnostic and Therapeutic Market Size and Forecast, By Application(2023-2030) 6.3. Europe Exosome Diagnostic and Therapeutic Market Size and Forecast, By End-User(2023-2030) 6.4. Europe Exosome Diagnostic and Therapeutic Market Size and Forecast, By Country (2023-2030) 6.4.1. United Kingdom 6.4.1.1. United Kingdom Exosome Diagnostic and Therapeutic Market Size and Forecast, By Product(2023-2030) 6.4.1.2. United Kingdom Exosome Diagnostic and Therapeutic Market Size and Forecast, By Application(2023-2030) 6.4.1.3. United Kingdom Exosome Diagnostic and Therapeutic Market Size and Forecast, By End-User(2023-2030) 6.4.2. France 6.4.2.1. France Exosome Diagnostic and Therapeutic Market Size and Forecast, By Product(2023-2030) 6.4.2.2. France Exosome Diagnostic and Therapeutic Market Size and Forecast, By Application(2023-2030) 6.4.2.3. France Exosome Diagnostic and Therapeutic Market Size and Forecast, By End-User(2023-2030) 6.4.3. Germany 6.4.3.1. Germany Exosome Diagnostic and Therapeutic Market Size and Forecast, By Product(2023-2030) 6.4.3.2. Germany Exosome Diagnostic and Therapeutic Market Size and Forecast, By Application(2023-2030) 6.4.3.3. Germany Exosome Diagnostic and Therapeutic Market Size and Forecast, By End-User(2023-2030) 6.4.4. Italy 6.4.4.1. Italy Exosome Diagnostic and Therapeutic Market Size and Forecast, By Product(2023-2030) 6.4.4.2. Italy Exosome Diagnostic and Therapeutic Market Size and Forecast, By Application(2023-2030) 6.4.4.3. Italy Exosome Diagnostic and Therapeutic Market Size and Forecast, By End-User(2023-2030) 6.4.5. Spain 6.4.5.1. Spain Exosome Diagnostic and Therapeutic Market Size and Forecast, By Product(2023-2030) 6.4.5.2. Spain Exosome Diagnostic and Therapeutic Market Size and Forecast, By Application(2023-2030) 6.4.5.3. Spain Exosome Diagnostic and Therapeutic Market Size and Forecast, By End-User(2023-2030) 6.4.6. Sweden 6.4.6.1. Sweden Exosome Diagnostic and Therapeutic Market Size and Forecast, By Product(2023-2030) 6.4.6.2. Sweden Exosome Diagnostic and Therapeutic Market Size and Forecast, By Application(2023-2030) 6.4.6.3. Sweden Exosome Diagnostic and Therapeutic Market Size and Forecast, By End-User(2023-2030) 6.4.7. Austria 6.4.7.1. Austria Exosome Diagnostic and Therapeutic Market Size and Forecast, By Product(2023-2030) 6.4.7.2. Austria Exosome Diagnostic and Therapeutic Market Size and Forecast, By Application(2023-2030) 6.4.7.3. Austria Exosome Diagnostic and Therapeutic Market Size and Forecast, By End-User(2023-2030) 6.4.8. Rest of Europe 6.4.8.1. Rest of Europe Exosome Diagnostic and Therapeutic Market Size and Forecast, By Product(2023-2030) 6.4.8.2. Rest of Europe Exosome Diagnostic and Therapeutic Market Size and Forecast, By Application(2023-2030) 6.4.8.3. Rest of Europe Exosome Diagnostic and Therapeutic Market Size and Forecast, By End-User(2023-2030) 7. Asia Pacific Exosome Diagnostic and Therapeutic Market Size and Forecast By Segmentation (By Value in USD Million) (2023-2030) 7.1. Asia Pacific Exosome Diagnostic and Therapeutic Market Size and Forecast, By Product(2023-2030) 7.2. Asia Pacific Exosome Diagnostic and Therapeutic Market Size and Forecast, By Application(2023-2030) 7.3. Asia Pacific Exosome Diagnostic and Therapeutic Market Size and Forecast, By End-User(2023-2030) 7.4. Asia Pacific Exosome Diagnostic and Therapeutic Market Size and Forecast, By Country (2023-2030) 7.4.1. China 7.4.1.1. China Exosome Diagnostic and Therapeutic Market Size and Forecast, By Product(2023-2030) 7.4.1.2. China Exosome Diagnostic and Therapeutic Market Size and Forecast, By Application(2023-2030) 7.4.1.3. China Exosome Diagnostic and Therapeutic Market Size and Forecast, By End-User(2023-2030) 7.4.2. S Korea 7.4.2.1. S Korea Exosome Diagnostic and Therapeutic Market Size and Forecast, By Product(2023-2030) 7.4.2.2. S Korea Exosome Diagnostic and Therapeutic Market Size and Forecast, By Application(2023-2030) 7.4.2.3. S Korea Exosome Diagnostic and Therapeutic Market Size and Forecast, By End-User(2023-2030) 7.4.3. Japan 7.4.3.1. Japan Exosome Diagnostic and Therapeutic Market Size and Forecast, By Product(2023-2030) 7.4.3.2. Japan Exosome Diagnostic and Therapeutic Market Size and Forecast, By Application(2023-2030) 7.4.3.3. Japan Exosome Diagnostic and Therapeutic Market Size and Forecast, By End-User(2023-2030) 7.4.4. India 7.4.4.1. India Exosome Diagnostic and Therapeutic Market Size and Forecast, By Product(2023-2030) 7.4.4.2. India Exosome Diagnostic and Therapeutic Market Size and Forecast, By Application(2023-2030) 7.4.4.3. India Exosome Diagnostic and Therapeutic Market Size and Forecast, By End-User(2023-2030) 7.4.5. Australia 7.4.5.1. Australia Exosome Diagnostic and Therapeutic Market Size and Forecast, By Product(2023-2030) 7.4.5.2. Australia Exosome Diagnostic and Therapeutic Market Size and Forecast, By Application(2023-2030) 7.4.5.3. Australia Exosome Diagnostic and Therapeutic Market Size and Forecast, By End-User(2023-2030) 7.4.6. Indonesia 7.4.6.1. Indonesia Exosome Diagnostic and Therapeutic Market Size and Forecast, By Product(2023-2030) 7.4.6.2. Indonesia Exosome Diagnostic and Therapeutic Market Size and Forecast, By Application(2023-2030) 7.4.6.3. Indonesia Exosome Diagnostic and Therapeutic Market Size and Forecast, By End-User(2023-2030) 7.4.7. Malaysia 7.4.7.1. Malaysia Exosome Diagnostic and Therapeutic Market Size and Forecast, By Product(2023-2030) 7.4.7.2. Malaysia Exosome Diagnostic and Therapeutic Market Size and Forecast, By Application(2023-2030) 7.4.7.3. Malaysia Exosome Diagnostic and Therapeutic Market Size and Forecast, By End-User(2023-2030) 7.4.8. Vietnam 7.4.8.1. Vietnam Exosome Diagnostic and Therapeutic Market Size and Forecast, By Product(2023-2030) 7.4.8.2. Vietnam Exosome Diagnostic and Therapeutic Market Size and Forecast, By Application(2023-2030) 7.4.8.3. Vietnam Exosome Diagnostic and Therapeutic Market Size and Forecast, By End-User(2023-2030) 7.4.9. Taiwan 7.4.9.1. Taiwan Exosome Diagnostic and Therapeutic Market Size and Forecast, By Product(2023-2030) 7.4.9.2. Taiwan Exosome Diagnostic and Therapeutic Market Size and Forecast, By Application(2023-2030) 7.4.9.3. Taiwan Exosome Diagnostic and Therapeutic Market Size and Forecast, By End-User(2023-2030) 7.4.10. Rest of Asia Pacific 7.4.10.1. Rest of Asia Pacific Exosome Diagnostic and Therapeutic Market Size and Forecast, By Product(2023-2030) 7.4.10.2. Rest of Asia Pacific Exosome Diagnostic and Therapeutic Market Size and Forecast, By Application(2023-2030) 7.4.10.3. Rest of Asia Pacific Exosome Diagnostic and Therapeutic Market Size and Forecast, By End-User(2023-2030) 8. South America Exosome Diagnostic and Therapeutic Market Size and Forecast By Segmentation (By Value in USD Million) (2023-2030) 8.1. South America Exosome Diagnostic and Therapeutic Market Size and Forecast, By Product(2023-2030) 8.2. South America Exosome Diagnostic and Therapeutic Market Size and Forecast, By Application(2023-2030) 8.3. South America Exosome Diagnostic and Therapeutic Market Size and Forecast, By End-User(2023-2030) 8.4. South America Exosome Diagnostic and Therapeutic Market Size and Forecast, By Country (2023-2030) 8.4.1. Brazil 8.4.1.1. Brazil Exosome Diagnostic and Therapeutic Market Size and Forecast, By Product(2023-2030) 8.4.1.2. Brazil Exosome Diagnostic and Therapeutic Market Size and Forecast, By Application(2023-2030) 8.4.1.3. Brazil Exosome Diagnostic and Therapeutic Market Size and Forecast, By End-User(2023-2030) 8.4.2. Argentina 8.4.2.1. Argentina Exosome Diagnostic and Therapeutic Market Size and Forecast, By Product(2023-2030) 8.4.2.2. Argentina Exosome Diagnostic and Therapeutic Market Size and Forecast, By Application(2023-2030) 8.4.2.3. Argentina Exosome Diagnostic and Therapeutic Market Size and Forecast, By End-User(2023-2030) 8.4.3. Rest Of South America 8.4.3.1. Rest of South America Exosome Diagnostic and Therapeutic Market Size and Forecast, By Product(2023-2030) 8.4.3.2. Rest of South America Exosome Diagnostic and Therapeutic Market Size and Forecast, By Application(2023-2030) 8.4.3.3. Rest of South America Exosome Diagnostic and Therapeutic Market Size and Forecast, By End-User(2023-2030) 9. Middle East and Africa Exosome Diagnostic and Therapeutic Market Size and Forecast By Segmentation (By Value USD Bn) (2023-2030) 9.1. Middle East and Africa Exosome Diagnostic and Therapeutic Market Size and Forecast, By Product(2023-2030) 9.2. Middle East and Africa Exosome Diagnostic and Therapeutic Market Size and Forecast, By Application(2023-2030) 9.3. Middle East and Africa Exosome Diagnostic and Therapeutic Market Size and Forecast, By End-User(2023-2030) 9.4. Middle East and Africa Exosome Diagnostic and Therapeutic Market Size and Forecast, By Country (2023-2030) 9.4.1. South Africa 9.4.1.1. South Africa Exosome Diagnostic and Therapeutic Market Size and Forecast, By Product(2023-2030) 9.4.1.2. South Africa Exosome Diagnostic and Therapeutic Market Size and Forecast, By Application(2023-2030) 9.4.1.3. South Africa Exosome Diagnostic and Therapeutic Market Size and Forecast, By End-User(2023-2030) 9.4.2. GCC 9.4.2.1. GCC Exosome Diagnostic and Therapeutic Market Size and Forecast, By Product(2023-2030) 9.4.2.2. GCC Exosome Diagnostic and Therapeutic Market Size and Forecast, By Application(2023-2030) 9.4.2.3. GCC Exosome Diagnostic and Therapeutic Market Size and Forecast, By End-User(2023-2030) 9.4.3. Rest Of MEA 9.4.3.1. Rest Of MEA Exosome Diagnostic and Therapeutic Market Size and Forecast, By Product(2023-2030) 9.4.3.2. Rest Of MEA Exosome Diagnostic and Therapeutic Market Size and Forecast, By Application(2023-2030) 9.4.3.3. Rest Of MEA Exosome Diagnostic and Therapeutic Market Size and Forecast, By End-User(2023-2030) 10. Company Profile: Key Players 10.1. Aethlon Medical, Inc. 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview (Total Revenue, Segment Revenue, and Regional Revenue) 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Recent Developments 10.2. Biocat Gmbh 10.3. Capricor Therapeutics, Inc. 10.4. Codiak Biosciences 10.5. Evox Therapeutics Ltd. 10.6. Exosome Diagnostics Inc. 10.7. Hansabiomed Life Sciences Ltd. 10.8. Hitachi Chemical Diagnostics, Inc. 10.9. Malvern Instruments Ltd. 10.10. Mbl International Corporation 10.11. Nanosomix Inc. 10.12. Sistemic Ltd. 10.13. System Biosciences (Sbi) 10.14. Thermo Fisher Scientific Inc. 10.15. Qiagen N.V. 10.16. NX Pharmagen. 10.17. AMS Biotechnology Limited 10.18. 101BIO Therapeutic Solutions International 10.19. BioRegenerative Sciences 10.20. Cell Guidance Systems 10.21. ExoCyte Therapeutics 10.22. Evomic Science 11. Key Findings 12. Analyst Recommendations 12.1. Attractive Opportunities for Players in the Exosome Diagnostic and Therapeutic Market 12.2. Future Outlooks 13. Exosome Diagnostic and Therapeutic Market: Research Methodology
